Trademarkia Logo

Canada

C$
INNOPEUTICS
REGISTERED

on 13 Oct 2021

Last Applicant/ Owned by

INNOPEUTICS CORPORATION

510 ho, (Seongsu-dong 2-ga,HausD Sejong Tower),26, Seongsuil-ro 10-gil,Seongdong-guSeoul

KR

Serial Number

1982817 filed on 12th Aug 2019

Registration Number

TMA1111263 registered on 13th Oct 2021

Registration expiry Date

31st May 2029

Correspondent Address

BENOÎT & CÔTÉ INC.

560 boul. Crémazie Est3e étageMontréal

QUEBEC

CA

H2P1E8

INNOPEUTICS

Trademark usage description

pharmaceutical preparations for the treatment of musculoskeletal disorders, namely, carpal tunnel syndrome and osteoarthritis; pharmaceutical preparat Read More

Vienna Information


26 . 5 . 1

One polygonUn polygone

26 . 5 . 12

Polygons containing one or more other geometrical figures Note: Including polygons containing bent or straight lines (except 26.5.10)Polygones contenant une ou plusieurs autres figures géométriques Note: Y compris les polygones contenant des lignes courbées ou droites (excepté 26.5.10)

26 . 5 . 24

Polygons with dark surfaces or parts of surfacesPolygones avec surface ou partie de la surface foncée

26 . 5 . 26

Polygons with cutout areasPolygones avec des zones découpées

26 . 7 . 21

Polygons with linesPolygones avec lignes

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 13

Wavy lines or bands, zigzag lines or bandsLignes ou bandes ondulées, en dents de scie

29 . 1 . 6

White, grey, silverBlanc, gris, argent

29 . 1 . 4

BlueBleu

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

29 . 1 . 5

VioletViolet

29 . 1 . 3

GreenVert

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of musculoskeletal disorders, namely, carpal tunnel syndrome and osteoarthritis; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical agents for treating the peripheral nervous system, namely, peripheral neuropathy; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cells, namely for immune cells, lymphocytopenia, skin cells, blood cells, genitourinary cells, hormonal cells, eye cells; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the prevention of disorders of the nervous system, namely Alzheimer's disease, cerebral palsy, Parkinson's disease, Amyotrophic lateral sclerosis, encephalitis, epilepsy, dysautonomia; pharmaceutical preparations for treating malignant tumours; pharmaceutical products for the treatment of viral and infectious diseases, namely, respiratory infections, eye infections, and for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, rheumatoid arthritis; biotechnological preparations for medical purposes, namely, for the treatment of cancer; pharmaceutical compositions, namely for autoimmune disease, allergy, hypertension, myocardial and cerebral infarction, vaccine, analgesic and medical diagnosis purposes; pharmaceuticals, namely for diabetes, liver disease, gout, hyperlipidemia, atherosclerosis, enzyme deficiency; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases, namely Alzheimer's disease, cerebral palsy, Parkinson's disease, Amyotrophic lateral sclerosis, encephalitis, epilepsy, dysautonomia.


Classification kind code

11

Mark Details


Serial Number

1982817

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 11th Mar 2021
Agent Changed
Submitted for opposition 22
on 12th Jan 2021
Search Recorded
Submitted for opposition 20
on 12th Jan 2021
Examiner's First Report
Submitted for opposition 223
on 12th Jan 2021
Total Provisional Refusal
Submitted for opposition 256
on 29th Jun 2020
Notification of Possible Opposition Sent
Submitted for opposition 257
on 29th Aug 2019
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 28th Aug 2019
Created
Submitted for opposition 31
on 28th Aug 2019
Formalized
Submitted for opposition 30
on 12th Aug 2019
Filed
Submitted for opposition 228
on 31st May 2019
International Registration